Institute of Microbiology and Biotechnology, University of Ulm, Ulm, Germany.
Faculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, Ås, Norway.
Metab Eng. 2021 Nov;68:34-45. doi: 10.1016/j.ymben.2021.09.002. Epub 2021 Sep 4.
Bacteriocins are antimicrobial peptides produced by bacteria to inhibit competitors in their natural environments. Some of these peptides have emerged as commercial food preservatives and, due to the rapid increase in antibiotic resistant bacteria, are also discussed as interesting alternatives to antibiotics for therapeutic purposes. Currently, commercial bacteriocins are produced exclusively with natural producer organisms on complex substrates and are sold as semi-purified preparations or crude fermentates. To allow clinical application, efficacy of production and purity of the product need to be improved. This can be achieved by shifting production to recombinant microorganisms. Here, we identify Corynebacterium glutamicum as a suitable production host for the bacteriocin pediocin PA-1. C. glutamicum CR099 shows resistance to high concentrations of pediocin PA-1 and the bacteriocin was not inactivated when spiked into growing cultures of this bacterium. Recombinant C. glutamicum expressing a synthetic pedACD operon releases a compound that has potent antimicrobial activity against Listeria monocytogenes and Listeria innocua and matches size and mass:charge ratio of commercial pediocin PA-1. Fermentations in shake flasks and bioreactors suggest that low levels of dissolved oxygen are favorable for production of pediocin. Under these conditions, however, reduced activity of the TCA cycle resulted in decreased availability of the important pediocin precursor l-asparagine suggesting options for further improvement. Overall, we demonstrate that C. glutamicum is a suitable host for recombinant production of bacteriocins of the pediocin family.
细菌素是细菌产生的抗菌肽,用于抑制其自然环境中的竞争者。其中一些肽已被用作商业食品防腐剂,并且由于抗生素耐药菌的迅速增加,它们也被讨论为抗生素治疗用途的有趣替代品。目前,商业细菌素仅由天然生产者在复杂的基质上生产,并作为半纯化制剂或粗发酵液出售。为了允许临床应用,需要提高生产效率和产品纯度。这可以通过将生产转移到重组微生物来实现。在这里,我们确定谷氨酸棒杆菌是细菌素肠球菌素 PA-1 的合适生产宿主。C. glutamicum CR099 对肠球菌素 PA-1 的高浓度表现出抗性,并且当将其掺入该细菌的生长培养物中时,该细菌素不会失活。表达合成 pedACD 操纵子的重组 C. glutamicum 释放出一种对单核细胞增生李斯特菌和无害李斯特菌具有强大抗菌活性的化合物,其大小和质荷比与商业肠球菌素 PA-1 相匹配。摇瓶和生物反应器中的发酵表明,低水平的溶解氧有利于肠球菌素的生产。然而,在这些条件下,三羧酸循环的活性降低导致重要的肠球菌素前体 l-天冬酰胺的可用性降低,这表明可以进一步改进。总的来说,我们证明谷氨酸棒杆菌是肠球菌素家族细菌素的重组生产的合适宿主。